$24.46 +2.19 (9.83%)

Assembly Biosciences, Inc (ASMB)

Assembly Biosciences, Inc. (ASMB) is a biotechnology company focused on developing therapies for viral infections and liver diseases. The company utilizes innovative approaches, including proprietary core platform technologies, to develop treatments for hepatitis B, other chronic viral infections, and microbiome-related conditions. Founded with a focus on advancing fundamental scientific research into therapeutic solutions, Assembly Biosciences aims to address unmet medical needs with its antiviral and microbiome-based therapies.

🚫 Assembly Biosciences, Inc does not pay dividends

Company News

Assembly’s NeosAI, Powered by Microsoft Azure AI Foundry, Sets New Benchmark for Legal Productivity—Backed by Real-World Results
GlobeNewswire Inc. • N/A • May 21, 2025

Assembly's NeosAI, built on Microsoft Azure AI Foundry, has demonstrated significant time savings and workflow automation for law firms, with advanced natural language processing and enterprise-grade security.

Insiders Buying American Software And 2 Other Stocks - American Software (NASDAQ:AMSWA) - Benzinga
Benzinga • Avi Kapoor • July 9, 2024

Insiders have been purchasing shares in American Software, Assembly Biosciences, and Tile Shop Holdings, indicating their confidence in the companies' prospects.

Are Medical Stocks Lagging Entera Bio (ENTX) This Year?
Zacks Investment Research • Zacks Equity Research • May 16, 2024

Here is how Entera Bio Ltd. (ENTX) and Assembly Biosciences (ASMB) have performed compared to their sector so far this year.

Penny Stocks To Buy Now? 6 To Watch With Big News Today
PennyStocks • J. Samuel • December 19, 2022

Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now? 6 To Watch With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.